Clinical trials

Economy & Jobs 15-03-2017

The Commission’s innovation confusion

Unless the European Commission changes its attitude, the innovation gap between Europe and the US will likely increase, and it could be overtaken soon by China, with dire consequences for living standards, warns Philip Stevens.

Health 07-02-2017

Rare cancers: A headache for policymakers

The complexity of diagnosing and treating rare forms of cancers like sarcomas can be addressed by a multi-level approach and better coordination among member states, insist experts in the field.

Health 02-02-2017

Lawmakers warn EU pharma industry about drug pricing

Pressure is mounting on pharmaceutical companies to reconsider the way they do business by refocusing their efforts on meeting patient needs and health outcomes rather than their own profits.

Health 19-01-2017

Germany votes to ease access to medical marijuana

The German Bundestag today (19 January) unanimously passed legislation granting seriously ill patients easier access to medical marijuana. EURACTIV Germany reports.

Health 11-01-2017

Tattoos could pose health risk says new Commission report

Ink used in tattoo parlours can contain low-purity pigments that are not meant to be applied to the skin and may pose a health risk, according to a European Commission report. EURACTIV Spain reports.

Health 03-11-2016

Alzheimer Europe chief: Holistic approach needed to tackle dementia

Alzheimer’s disease and other forms of dementia remain underdiagnosed in most European countries, Jean Georges told EURACTIV.

Health 21-10-2016

Andriukaitis: Health Technology Assessment will make EU healthcare ‘sustainable’

EXCLUSIVE / National healthcare systems should embrace the digital era and use Health Technology Assessment (HTA) to become truly sustainable and cost-effective, European Commissioner for Health and Food Safety Vytenis Andriukaitis told EURACTIV.com in an interview.

Health 01-09-2016

EU’s sunbed safety assessment clouded by bias

An upcoming assessment by a European Commission committee on the risks of UV radiation and sunbeds is hamstrung by in-built bias and a failure to comprehensively address all the issues, warns Frank Harbusch.

Development Policy 23-08-2016

Brexit casts doubt over Uganda development project on lung disease

The UK's vote to leave the European Union has come at a crucial moment in the development of an international medical project that throws into sharp relief the state of flux Brexit has cast over collaborative research, says Jack Barton.

Health 01-08-2016

EU drugs agency to unveil results on ‘early medicines’ project this week

The European Medicines Agency (EMA) will this week publish the much-awaited results of a pilot project on the early marketing authorisation of drugs, EURACTIV has learnt.

Health 26-07-2016

Pharma expert: new ‘value added medicines’ offer cheaper, customised treatment

A new breed of drugs, called “value added medicines”, could help patients improve their everyday life while in treatment, without increasing healthcare budgets, Christoph Stoller said in an interview with EURACTIV.com

Health 13-06-2016

New medical devices rules should avoid ‘unnecessary’ red tape, industry says

The implementation of new rules on medical devices should avoid extra burdens and unnecessary bureaucracy, health industry officials have told EURACTIV.com.

EU project hopes to phase out animal-testing

When chemicals are considered too dangerous to be tested on humans, animals have long been the answer to some scientific quandaries. The EU project ToxRisk will act as Europe's flagship for safety assessments that do not require the use of animals. EURACTIV Germany reports.

Supermarket
Agrifood 20-11-2015

Food industry wants common science principles to boost trust

The EU's food and drinks industry has developed a set of principles for research conduct that will apply to the sector.

Ben Goldacre
Health 22-10-2014

Ben Goldacre: Pharma industry has destroyed its own reputation

EXCLUSIVE: The great tragedy for the pharmaceutical industry is that it keeps denying that it lobbies against transparency in clinical trials, says Ben Goldacre.

Pills

EU Ombudsman: Clinical trials face new transparency challenges

Medical researchers in Europe are facing new challenges over access to clinical trials data, according to the European Ombudsman Emily O'Reilly.

31 drugs intended to treat cancer were approved by the European Medicines Agency (EMA) over the past three years. 2011 [Interpharma/Flickr]

Cancer research at a crossroads in Germany

A new EU regulation is meant to make clinical trials easier and more transparent, a pivotal tool in the fight against deadly diseases like cancer. But researchers in Germany warn that the country may lose its role as a leader in international medicine. EURACTIV Germany reports.

Pills
Health 11-06-2014

Growing concerns over medicines agency’s proposed rules for transparency

A growing number of health and consumer advocacy organisations are urging the European Medicines Agency (EMA) to rethink its proposals to restrict the viewing of clinical trial results ahead of a board meeting Thursday (12 June).

Pills
Health 21-05-2014

EU Ombudsman worried over lack of transparency at medicines agency

The European Ombudsman, Emily O'Reilly, has written to the European Medicines Agency (EMA), expressing concern about a significant change of clinical trial data transparency policy.

EU rules ‘mean children can’t get life-saving cancer drugs’

Children with cancer are being denied access to potentially life-saving medicines because European Union rules allow drug firms to waive the need to test some drugs in paediatric trials, researchers said on Monday (10 February).

Health 20-12-2013

EU Parliament, ministers agree to more clinical trial transparency in clinical trials

MEPs reached on Friday (20 December) an agreement with member states on the clinical trials directive.

Health 22-10-2013

Ending drug trial secrecy is a boon for R&D, says EU agency

Europe's medicines regulator has come out fighting for greater transparency for clinical trials, arguing that its controversial policy to end data secrecy will be "a boon to drug developers".

Health 29-08-2013

Health experts critical of pharma industry’s new transparency rules

The European pharmaceutical industry association EFPIA has published new ethical commitments on clinical trials aimed at allaying accusations that a lack of transparency on how new drugs are tested is hurting patients. Critics however are unconvinced.

Health 25-07-2013

Pharma industry downplays lobbyism with patient groups

In a blog entry posted yesterday (24 July), the director general of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Richard Bergström, rebuffed reports that the pharmaceutical industry is trying to limit transparency as it seeks to work together with patient groups on clinical trials.

  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5970]
      public 'ID' => int 1128597
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2017-03-20 07:06:21' (length=19)
      public 'post_date_gmt' => string '2017-03-20 06:06:21' (length=19)
      public 'post_content' => string '<strong>The European Union is exploring ways of helping its Common Agricultural Policy (CAP) enter the digital era after 2020.</strong>
    
    But numerous challenges still lie ahead, ranging from e-skills building, lack of broadband infrastructure and Big Data management.
    
    <a href="http://pdf.euractiv.com/view/EURACTIV%20Special%20Report%202017.03%20-%20EU%20farming%20getting%20smarter.pdf"><strong><em>Click here to download this Special Report.</em></strong></a>' (length=468)
      public 'post_title' => string 'EU farming getting smarter' (length=26)
      public 'post_excerpt' => string 'The European Union is exploring ways of helping its Common Agricultural Policy (CAP) enter the digital era after 2020.' (length=119)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'eu-farming-getting-smarter' (length=26)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-04-13 12:00:39' (length=19)
      public 'post_modified_gmt' => string '2017-04-13 10:00:39' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'https://beta.euractiv.com/?post_type=special_report&#038;p=1128597' (length=66)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5885]
      public 'ID' => int 1125442
      public 'post_author' => string '34930' (length=5)
      public 'post_date' => string '2017-03-20 06:30:30' (length=19)
      public 'post_date_gmt' => string '2017-03-20 05:30:30' (length=19)
      public 'post_content' => string 'The #Media4EU editorial series interviewed more than 30 media experts from six countries about the parallel between the crises facing the sector and those facing Europe itself, as well as ways to foster better cooperate.
    
    The series is a result of a cooperation project between Fondation EURACTIV and the Université Libre de Bruxelles.
    
    Several issues feed discussion at European level too: fake news and populism, shrinking business models, and the review of the Digital Single Market.
    
    Solutions could'... (length=1088)
      public 'post_title' => string '#Media4EU: Can innovation beat the crises facing the EU and media?' (length=66)
      public 'post_excerpt' => string 'The #Media4EU editorial series interviewed more than 30 media experts from six countries about the parallel between the crises facing the sector and those facing Europe itself, as well as ways to foster better cooperate.' (length=222)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'media4eu-can-innovation-beat-the-crises-in-media-and-the-eu' (length=59)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-03-23 06:12:22' (length=19)
      public 'post_modified_gmt' => string '2017-03-23 05:12:22' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1125442' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '1' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5882]
      public 'ID' => int 1127413
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2017-03-15 13:44:38' (length=19)
      public 'post_date_gmt' => string '2017-03-15 12:44:38' (length=19)
      public 'post_content' => string 'Biotechnology could help patients across Europe gain access to innovative therapies, for example, against rare diseases. Proponents of bio-medicines also claim that precision therapy, because it is more efficient, will ease the burden on member states’ ailing healthcare systems.
    
    Biotechnology is the use of living systems or organisms in the creation of industrial products. In Europe, it has created 10,000 new jobs and 93 medicines recommended for market authorisation by the European Medicines Agency in'... (length=791)
      public 'post_title' => string 'Biomedicines in Europe' (length=22)
      public 'post_excerpt' => string 'Biotechnology could help patients across Europe gain access to innovative therapies, for example, against rare diseases. Proponents of bio-medicines also claim that precision therapy, because it is more efficient, will ease the burden on member states’ ailing healthcare systems.' (length=281)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'biomedicines-in-europe' (length=22)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-03-17 10:28:16' (length=19)
      public 'post_modified_gmt' => string '2017-03-17 09:28:16' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1127413' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5864]
      public 'ID' => int 1094356
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2017-02-27 06:44:47' (length=19)
      public 'post_date_gmt' => string '2017-02-27 05:44:47' (length=19)
      public 'post_content' => string '<a href="http://pdf.euractiv.com/view/EURACTIV-Special-Report-2017.02-_-MWC2017-The-power-behind-the-tech-revolution.pdf"><strong>Read this Special Report online.</strong></a>
    
    The Mobile World Congress, being held in Barcelona from 27 February to 2 March, will bring together industry representatives, regulators and politicians to discuss current challenges and future opportunities posed by the digital revolution.
    
    Artificial Intelligence, the Internet of Things, virtual reality, 'big data',  self-lea'... (length=718)
      public 'post_title' => string 'MWC17: The power behind the tech revolution' (length=43)
      public 'post_excerpt' => string 'The Mobile World Congress, to be held in Barcelona from 27 February to 2 March, will bring together industry representatives, regulators and politicians to discuss current challenges and future opportunities posed by the digital revolution.' (length=241)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'mwc17-the-power-behind-the-tech-revolution' (length=42)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-03-22 10:20:20' (length=19)
      public 'post_modified_gmt' => string '2017-03-22 09:20:20' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1094356' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5931]
      public 'ID' => int 1091484
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2017-02-20 13:44:54' (length=19)
      public 'post_date_gmt' => string '2017-02-20 12:44:54' (length=19)
      public 'post_content' => string '<a href="http://pdf.euractiv.com/view/EURACTIV-Special-Report-2017.02-_-Agricultural-trade.pdf"><strong>Read this Special Report online.</strong></a>
    
    Can new niche markets save EU farmers’ income? What should the post-2020 Common Agricultural Policy look like in order to support an export-driven farming sector?
    
    The Russian embargo has put enormous pressure on already struggling European Union agricultural markets. Trade between Russia and the EU dropped by more than €163.4bn between 2013 and last '... (length=1345)
      public 'post_title' => string 'Agricultural trade' (length=18)
      public 'post_excerpt' => string 'Can new niche markets save EU farmers’ income? How should the post-2020 Common Agricultural Policy look like in order to support an export-driven farming sector?' (length=163)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'agricultural-trade' (length=18)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-03-22 10:18:18' (length=19)
      public 'post_modified_gmt' => string '2017-03-22 09:18:18' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1091484' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5865]
      public 'ID' => int 1091406
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2017-02-20 06:28:44' (length=19)
      public 'post_date_gmt' => string '2017-02-20 05:28:44' (length=19)
      public 'post_content' => string '<strong><a href="http://pdf.euractiv.com/view/EURACTIV-Special-Report-2017.02-_-Agricultural-trade.pdf">Read this Special Report online.</a></strong>
    
    In a series of articles, euractiv.com looks at the situation in Montenegro following the 16 October elections, when an alleged ‘coup’ was staged against the background of a geopolitical tug-of-war over the small country’s NATO bid.' (length=390)
      public 'post_title' => string 'Montenegro: Breaking the stalemate?' (length=35)
      public 'post_excerpt' => string 'In a series of articles, Euractiv.com looks at the situation in Montenegro following the 16 October elections, when an alleged ‘coup’ was staged against the background of a geopolitical tug-of-war over the small country’s NATO bid.' (length=237)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'montenegro-breaking-the-stalemate' (length=33)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-03-22 10:19:44' (length=19)
      public 'post_modified_gmt' => string '2017-03-22 09:19:44' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1091406' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5946]
      public 'ID' => int 1087632
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2017-02-07 06:09:00' (length=19)
      public 'post_date_gmt' => string '2017-02-07 05:09:00' (length=19)
      public 'post_content' => string '<a href="http://pdf.euractiv.com/view/EURACTIV-Special-Report-2017.02-_-Rare-cancers-_-Cracking-the-code.pdf">Read this Special Report online</a>.
    
    The growing number of cases of rare diseases has raised eyebrows in the EU and policymakers are now exploring ways to understand and tackle the complexity of the phenomenon.
    
    Rare cancers – those with fewer than five cases out of 10,000 – belong to this category. It may look small, but according to European Commission estimates, about 246,000 people '... (length=798)
      public 'post_title' => string 'Rare cancers: Cracking the code' (length=31)
      public 'post_excerpt' => string 'The growing number of cases of rare diseases has raised eyebrows in the EU and policymakers are now exploring ways to understand and tackle the complexity of the phenomenon.' (length=173)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'rare-cancers-cracking-the-code' (length=30)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-03-22 10:11:30' (length=19)
      public 'post_modified_gmt' => string '2017-03-22 09:11:30' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1087632' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • /home/euractiv/src/wp-content/themes/euractiv/templates/archive.php:104:
    object(WP_Post)[5900]
      public 'ID' => int 1073222
      public 'post_author' => string '239' (length=3)
      public 'post_date' => string '2016-12-19 16:13:50' (length=19)
      public 'post_date_gmt' => string '2016-12-19 15:13:50' (length=19)
      public 'post_content' => string 'Although death rates have fallen substantially, cardiovascular disease (CVD) remains the single biggest killer in the UK and Europe, as well as a sizeable economic burden. EURACTIV looks at the many facets of CVD.
    
    Cardiovascular disease accounts for 52% of female deaths and 42% of male deaths in the EU. Approximately four million people in Europe and 1.9 million people in the EU die of cardiovascular disease each year, according to the European Society of Cardiology.
    
    To reduce the number of deaths fr'... (length=1116)
      public 'post_title' => string 'Cardiovascular health in the UK' (length=31)
      public 'post_excerpt' => string 'Although death rates have fallen substantially, cardiovascular disease remains the single biggest killer in the UK and Europe, as well as a sizeable economic burden. EURACTIV looks at the many facets of cardiovascular disease.' (length=227)
      public 'post_status' => string 'publish' (length=7)
      public 'comment_status' => string 'open' (length=4)
      public 'ping_status' => string 'closed' (length=6)
      public 'post_password' => string '' (length=0)
      public 'post_name' => string 'cardiovascular-health-in-the-uk' (length=31)
      public 'to_ping' => string '' (length=0)
      public 'pinged' => string '' (length=0)
      public 'post_modified' => string '2017-01-16 11:07:39' (length=19)
      public 'post_modified_gmt' => string '2017-01-16 10:07:39' (length=19)
      public 'post_content_filtered' => string '' (length=0)
      public 'post_parent' => int 0
      public 'guid' => string 'http://beta.euractiv.com/?post_type=special_report&#038;p=1073222' (length=65)
      public 'menu_order' => int 0
      public 'post_type' => string 'special_report' (length=14)
      public 'post_mime_type' => string '' (length=0)
      public 'comment_count' => string '0' (length=1)
      public 'filter' => string 'raw' (length=3)
    
  • EU farming getting smarter

    #Media4EU: Can innovation beat the crises facing the EU and media?

    Biomedicines in Europe

    MWC17: The power behind the tech revolution

    Agricultural trade

    Montenegro: Breaking the stalemate?

    Rare cancers: Cracking the code

    Cardiovascular health in the UK

    Subscribe to our newsletters

    Subscribe